This is one of the hardest subjects in any discussion of cannabis and health. A competent adult has the right to refuse treatment. The published outcomes of that particular choice are poor. Both statements are true, and the person who has to hold them together is usually frightened and out of time.
This article is not medical advice, not legal advice, and not a recommendation either way. It does not tell anyone to accept or decline any treatment. It sets out what the published outcome data shows, what the general legal principles are, and where the person giving advice stands — because that last question is the one almost nobody asks and the one most likely to end badly. If you are facing this decision, the people who can help you are your oncology team and, on the legal points, a qualified lawyer in your jurisdiction.
1. Three Questions That Get Mixed Together
Discussion of this subject collapses into argument because three separate questions get answered as if they were one.
- May a competent adult refuse treatment? This is a settled question of law and ethics in most jurisdictions, and the answer is yes.
- What is known about the outcomes of this specific choice? This is an empirical question with published data.
- What is the position of the person who encouraged the refusal? This is a legal question, and it has a different answer from question 1.
Conflating them produces the two standard bad arguments: “it’s my body, so the data doesn’t apply to me” — which confuses a right with a prediction — and “the data is bad, so you shouldn’t be allowed to choose” — which confuses a prediction with a right. Both are wrong for the same reason.
2. The Adult’s Right to Refuse
The principle of informed consent has a necessary corollary: a person who can consent can also decline. In most legal systems an adult with decision-making capacity may refuse a medical intervention even where refusal is expected to result in death, and may do so for reasons that others consider mistaken, irrational or based on beliefs they do not share. In common-law systems such as England’s, treating a competent adult without consent is, in general terms, a battery (an unlawful touching), however beneficial the treatment would have been.
Capacity is the hinge, and capacity is decision-specific. One well-known model is the test in the UK’s Mental Capacity Act 2005. It asks whether the person can understand the relevant information, retain it, weigh it in reaching a decision, and communicate that decision. Under that Act capacity is presumed in adults, and disagreeing with the doctor is not evidence of incapacity. Other countries word the test differently, but the underlying ideas are widely shared. A person may have capacity for one decision and not another, and capacity can fluctuate with illness, with medication and with pain.
In Thailand, the explicit statutory right is narrower. Section 12 of the National Health Act B.E. 2550 allows a person to make a written advance directive (living will) refusing health services that merely prolong the terminal stage of life, or to end severe suffering from illness. The procedure is set by a Ministerial Regulation (B.E. 2553), and health personnel who act on a valid directive are not liable for doing so. Section 12 is about the end of life. It does not, on its own terms, cover a decision to decline curative treatment. The broader principle of informed consent and informed refusal appears in the Declaration of Patient’s Rights and Duties issued in 2015 by the Medical Council of Thailand together with other health professional councils. Under it, a patient has the right to sufficient information before deciding whether to accept treatment (except in an emergency) and to seek a second opinion, and parents or guardians exercise these rights for patients under 18. The declaration is a professional standard, not an Act of Parliament. Thai legal commentators have noted that it sets out broad principles rather than a detailed legal procedure.
It is worth being explicit about what follows: a patient who has understood the prognosis with and without treatment, and declines anyway, has exercised a right, not made an error that needs correcting. Clinicians in that situation are not obliged to agree, and are obliged to keep the door open.
3. What the Outcome Data Shows
A person exercising that right is entitled to accurate information about what it costs. The most-cited outcome studies (Johnson and colleagues, 2018) found markedly worse survival in patients with curable cancers who used alternative medicine instead of conventional treatment. The excess deaths among people who used complementary medicine alongside treatment were explained by their higher rate of refusing conventional treatment. The measurable harm is linked to refusal, not to use. These are observational studies about alternative medicine in general, not cannabis specifically. Separately, an observational study of patients with advanced cancer on immune checkpoint inhibitor immunotherapy found an association between cannabis use and shorter time to progression and shorter survival. Confounding cannot be excluded, and the study does not prove a drug interaction. The figures and caveats are covered in Cannabis and Cancer (topic 1308) and, for one widely promoted preparation, Rick Simpson Oil (topic 1314).
4. What Informed Refusal Actually Looks Like
The ethical answer to a patient who wants to decline is not persuasion and not abandonment. It is process.
- Assess capacity properly where there is genuine reason to doubt it — not because the decision is unwelcome.
- Disclose specifically. Not “you should have the chemotherapy,” but the expected outcome with treatment, the expected outcome without it, and how uncertain both estimates are for this individual.
- Establish what is driving the refusal. Fear of a specific side effect, a bad experience of a relative, cost, distrust, or a belief about an alternative are different problems with different answers; several are addressable without anyone changing their position on the substance.
- Separate the two decisions. Declining chemotherapy and taking a cannabis preparation are independent choices. A patient can decline one treatment and still accept surgery, radiotherapy, symptom control or palliative care. Refusal is not all-or-nothing and should not be framed that way.
- Document the discussion.
- Leave the door open. People change their minds, and the ones who do should not have to overcome embarrassment to come back.
5. Where a Minor Is Involved: General Principles Only
This article does not discuss any individual case involving a child, and posting details of a child’s case in a public forum is best avoided. Posting rules are set out in the Community Guidelines (topic 133). What follows is stated at the level of principle.
A child’s parents are decision-makers, but their authority is not unlimited. Across most legal systems the governing standard for a decision about a child’s medical care is the best interests of the child, and where a parental decision is judged to fall outside that standard, courts have jurisdiction to authorise treatment over the parents’ objection. This is the point at which the adult right described in section 2 stops, because the person exercising it is not the person whose life is at stake.
Adolescents occupy contested ground. Many jurisdictions recognise that a sufficiently mature minor may consent to treatment. Fewer treat that as symmetrical: a mature minor’s refusal of life-preserving treatment is frequently subject to a higher threshold or to override, and the law here differs substantially between countries and is genuinely unsettled.
Two practical consequences follow. A parent making this decision for a child is not in the same legal position as an adult making it for themselves, and should be told so plainly. And anyone offering advice about a child’s cancer treatment is in the most legally exposed position described in this article.
6. The Adviser’s Position
This section is written for anyone who answers health questions online, and it is the reason the article exists.
Giving individual treatment advice is a regulated activity. Under Thailand’s Medical Profession Act B.E. 2525, “the medical profession” is defined to include examination, diagnosis, treatment and prevention of disease. Section 26 provides that no one shall carry out medical practice, or represent that they are ready to carry it out, unless licensed under the Act. Section 43 provides that a violation is punishable by imprisonment not exceeding three years, a fine not exceeding 30,000 baht, or both. That is still the penalty in force. A draft amendment put out for public comment in August 2026 proposes raising it to five years and 500,000 baht, but it is not law. The Act’s exemptions cover self-treatment, uncompensated emergency aid, supervised students, authorised government and charitable personnel, licensed traditional practitioners within their scope, and authorised foreign experts. Whether an online post amounts to medical practice under s.26 has not been clearly tested; posts that diagnose or prescribe for a named person carry the most risk.
The phrase “or represent that he is ready to carry out” is the part most people miss. On its wording, it does not require that anyone was harmed, or that money changed hands.
Advertising and therapeutic claims are separately regulated. Under the Notification of the Ministry of Public Health Re: Controlled Herbs (Cannabis) B.E. 2568, issued on 26 June 2025 under the Protection and Promotion of Traditional Thai Medicinal Intelligence Act B.E. 2542, cannabis flower is a controlled herb. It may be dispensed only against a prescription on form PT 33 from an authorised practitioner, for no more than 30 days per prescription and with no refills, and advertising and online sale are prohibited. Press reports of the penalties for selling without a valid prescription are inconsistent, so check them against the Thai-language Royal Gazette text before relying on any figure. Separately, extracts above 0.2% THC remain Category 5 narcotics. Two Ministerial Regulations of B.E. 2569 tightened licensing in 2026: one on cannabis and hemp extracts (in force 26 April 2026) and the No. 2 regulation on controlled-herb licences (in force 30 April 2026). Neither changes the PT 33 prescription rules.
Put together: a post that combines a health claim with a route to obtain the product is exposed on more than one front at once. Adding “this is not medical advice” to the end of a message that plainly gives medical advice does not change what the message is.
And there is a moral exposure that no statute captures. If somebody declines curative treatment because of something you wrote, you will not be told, and you will not find out. That asymmetry is worth sitting with before posting.
7. What This Means When Posting
The binding posting rules are in the Community Guidelines (topic 133). As general good practice when health questions come up:
| Appropriate | Not appropriate |
|---|---|
| Describing your own experience, in the past tense, as your own | Telling another member what to take, or what to stop |
| Linking published evidence and discussing what it shows | Advising anyone to decline or delay treatment |
| Explaining what a prescriber told you | Diagnosing, staging, or interpreting someone’s results |
| Encouraging someone to talk to their oncology team | Offering to supply anything, to anyone |
| Discussing legal and regulatory frameworks in general terms | Presenting general information as advice for one person’s case |
If someone arrives in acute distress after a diagnosis, the useful reply is not a protocol. It is to acknowledge them, and to encourage them to put the question — including the question about cannabis — to the team treating them. That is not a brush-off. It is the only route to an answer that accounts for their actual disease, stage and medications.
8. What a Clinician Can Do
Refusal is not the end of a relationship. Symptom control, palliative care and monitoring remain available and should be offered explicitly, because patients frequently assume that declining one treatment means declining all care.
And the practical request that matters most: ask what else they are taking, without judgement, and tell them why you are asking. Patients conceal it because they expect a reaction. What is concealed cannot be checked for interactions — with anticoagulation, with immunotherapy, with drugs metabolised by the same enzymes — and cannot be considered when a laboratory result comes back unexplained.
If you are a clinician in Thailand or the region who has had this conversation with a patient, what made it go better or worse? And if you are a patient or a carer who has faced the decision, what information did you most need at the time and not have? Please do not post anything that could identify another person.
General information only — not medical advice and not legal advice. Legal provisions are summarised from published sources as of October 2026 and may change; verify current requirements with a qualified professional before relying on them.